PATRICK FOURTEAU Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PATRICK FOURTEAU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PATRICK FOURTEAU. PATRICK FOURTEAU is Director in REPROS THERAPEUTICS INC. ($RPRX) and President and CEO in REPROS THERAPEUTICS INC. ($RPRX) and CEO and President in SCIELE PHARMA, INC. ($FHRX) and Director in Insys Therapeutics, Inc. ($INSY).
Latest Insider Trading Transactions of PATRICK FOURTEAU
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, INSY, RPRX, FHRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Option Exercise | D | 0.32 | 5,000 | 1,600 | 0 | |
| Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Sell | D | 0.67 | 27,779 | 18,612 | 0 | 27.8 K to 0 (-100.00 %) |
| Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Sell | U | 0.67 | 12,221 | 8,188 | 27,779 | 40 K to 27.8 K (-30.55 %) |
| Sep 18 2017 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | President and CEO | Option Exercise | A | 0.32 | 5,000 | 1,600 | 5,000 | |
| Aug 04 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | M | 1.62 | 10,000 | 16,200 | 63,770 | |
| Aug 04 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Buy | M | 1.62 | 10,000 | 16,200 | 69,682 | 59.7 K to 69.7 K (+16.76 %) |
| May 26 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | M | 3.63 | 10,000 | 36,300 | 50,000 | |
| May 26 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Buy | M | 3.63 | 10,000 | 36,300 | 59,682 | 49.7 K to 59.7 K (+20.13 %) |
| Feb 23 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
| Feb 23 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | A | 12.65 | 16,000 | 202,400 | 16,000 | |
| Feb 15 2017 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
| Aug 12 2016 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 18.46 | 15,000 | 276,900 | 49,682 | 64.7 K to 49.7 K (-23.19 %) |
| Aug 12 2016 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 18.46 | 15,000 | 276,900 | 49,682 | 64.7 K to 49.7 K (-23.19 %) |
| Jul 05 2016 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Option Exercise | A | 1.61 | 5,000 | 8,050 | 5,000 | |
| May 16 2016 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Option Exercise | A | 2.06 | 100,000 | 206,000 | 100,000 | |
| May 04 2016 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | A | 14.44 | 25,000 | 361,000 | 25,000 | |
| Mar 04 2016 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 18.22 | 15,000 | 273,300 | 64,682 | 79.7 K to 64.7 K (-18.82 %) |
| Nov 13 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 26.48 | 30,000 | 794,400 | 79,682 | 109.7 K to 79.7 K (-27.35 %) |
| May 27 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 60.14 | 1,311 | 78,844 | 54,841 | 56.2 K to 54.8 K (-2.33 %) |
| May 27 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 60.00 | 4,784 | 287,040 | 56,152 | 60.9 K to 56.2 K (-7.85 %) |
| May 20 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 60.00 | 6,095 | 365,700 | 60,936 | 67 K to 60.9 K (-9.09 %) |
| May 20 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 60.00 | 2,969 | 178,140 | 67,031 | 70 K to 67 K (-4.24 %) |
| May 07 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | A | 53.50 | 9,000 | 481,500 | 9,000 | |
| Mar 12 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 59.94 | 10,000 | 599,359 | 70,000 | 80 K to 70 K (-12.50 %) |
| Dec 14 2004 | FHRX | SCIELE PHARMA, INC ... | FOURTEAU PATRICK | CEO and President | Option Exercise | A | 21.36 | 100,000 | 2,136,000 | 100,000 | |
| Dec 14 2004 | FHRX | SCIELE PHARMA, INC ... | FOURTEAU PATRICK | CEO and President | Option Exercise | X | 10.47 | 47,500 | 497,325 | 150,000 | |
| Dec 14 2004 | FHRX | SCIELE PHARMA, INC ... | FOURTEAU PATRICK | CEO and President | Option Exercise | X | 3.80 | 100,000 | 380,000 | 0 | |
| Dec 14 2004 | FHRX | SCIELE PHARMA, INC ... | FOURTEAU PATRICK | CEO and President | Option Exercise | X | 2.52 | 52,500 | 132,300 | 167,500 | |
| Dec 14 2004 | FHRX | SCIELE PHARMA, INC ... | FOURTEAU PATRICK | CEO and President | Sell | S | 23.19 | 200,000 | 4,638,000 | 330,424 | 530.4 K to 330.4 K (-37.71 %) |
| Dec 14 2004 | FHRX | SCIELE PHARMA, INC ... | FOURTEAU PATRICK | CEO and President | Buy | M | 23.19 | 200,000 | 4,638,000 | 530,424 | 330.4 K to 530.4 K (+60.53 %) |
| Dec 14 2004 | FHRX | SCIELE PHARMA, INC ... | FOURTEAU PATRICK | CEO and President | Option Exercise | A | 21.36 | 100,000 | 2,136,000 | 100,000 | |
| Dec 14 2004 | FHRX | SCIELE PHARMA, INC ... | FOURTEAU PATRICK | CEO and President | Option Exercise | X | 10.47 | 47,500 | 497,325 | 150,000 | |
| Dec 14 2004 | FHRX | SCIELE PHARMA, INC ... | FOURTEAU PATRICK | CEO and President | Option Exercise | X | 3.80 | 100,000 | 380,000 | 0 | |
| Dec 14 2004 | FHRX | SCIELE PHARMA, INC ... | FOURTEAU PATRICK | CEO and President | Option Exercise | X | 2.52 | 52,500 | 132,300 | 167,500 | |
| Dec 14 2004 | FHRX | SCIELE PHARMA, INC ... | FOURTEAU PATRICK | CEO and President | Sell | S | 23.19 | 200,000 | 4,638,000 | 330,424 | 530.4 K to 330.4 K (-37.71 %) |
| Dec 14 2004 | FHRX | SCIELE PHARMA, INC ... | FOURTEAU PATRICK | CEO and President | Buy | M | 23.19 | 200,000 | 4,638,000 | 530,424 | 330.4 K to 530.4 K (+60.53 %) |
Page: 1